Valley Cottage, NY 10/19/2018 3 D surgical microscope system is an electrically or mechanically worked optical magnifying instrument intended for use in surgical settings for performing microsurgeries. The mix of focal points give stereoscopic vision, amplification going from 4 x 40 x, and enlightened picture of the surgical zone. It has r
ABBOTT PARK, Ill., Oct. 19, 2018/ PRNewswire/ Abbott announced today that the HeartMate 3? Left Ventricular Assist Device has received U.S. Food and Drug Administration approval as a destination therapy for people living with advanced heart failure. "Approximately a quarter of a million people are living with advanced heart failure, and many o
NORTH CHICAGO- AbbVie, a research-based global biopharmaceutical company, and Morphic Therapeutic, a biotechnology company developing oral integrin therapies, announced today that the companies have entered into a research and development collaboration designed to advance a number of Morphic's oral integrin therapeutics for fibrosis-related...
NEW YORK and CLEVELAND- Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of Joao Siffert, M.D. as Head of Research and Development and Chief Medical Officer. Both Dr. Siffert and Ms. Patil repor
In response to opinions expressed following the U.S. Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee meeting on October 12, AcelRx Pharmaceuticals, Inc. stands by the safety, efficacy and medical need for its investigational therapy, DSUVIA?. Developed in collaboration with the Department of Defense, DSUVI
-AIT Therapeutics, Inc., a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today presented a poster with data on high-dose in vitro inhaled NO at the North American Cystic...
LAKE FOREST- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that the company filed a notice of appeal to the Supreme Court of the State of Delaware from the recent decision of the Delaware Court of Chancery rejecting Akorn's claims. Akorn, Inc. is a specialty generic pharmaceutical company engaged in the developmen
NEWTON- Allena Pharmaceuticals, Inc., a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced presentations at two upcoming medical meetings. At the 2018 American College of Rheumatology Annual.
Allergan plc, a leading global pharmaceutical company with a nearly 70- year heritage in ophthalmology, will present new data at the Annual Meeting of the American College of Ophthalmology to be held in Chicago, Illinois. "The data demonstrate our continued dedication to research and innovation aimed at finding new solutions to a cross-section o
Almirall, LLC, formerly Aqua Pharmaceuticals, a U.S. leader in skin health medical solutions, used the start of the Fall Clinical Dermatology Congress to officially launch their new name. Almirall, LLC is part of the larger Almirall, S.A. family, an internationally-recognized global dermatology pharmaceutical company, with a strong focus on skin
Amneal Pharmaceuticals, Inc., today announced that it has received FDA approval for a generic version of BiCNU for injection, 100 mg. About Amneal Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar
Amneal Pharmaceuticals, Inc., today announced that it has received FDA approval for a generic version of Isuprel TM Injection USP, 0.2 mg/mL and 1 mg/5 mL Single-Dose Vials. About Amneal Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distri
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer s disease, Rett syndrome and other central nervous system diseases, today announced that the Company has received confirmation from the U.S. Foo
Analyst Ratings For Anavex Life Sciences Corp (NASDAQ:AVXL) Today, Maxim Group set its price target on Anavex Life Sciences Corp (NASDAQ:AVXL) to $7.00 per share. There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus rating on Anavex Life Sciences Corp (NASDAQ:AVXL) is Buy [?]
Valley Cottage, NY 10/19/2018 Antisense oligonucleotides are 15 25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disord
Albany, NY 10/19/2018 Apocarotenal belongs to the group of plant substances called the carotenoid. The presence of Apocarotenal is usually seen in the citrus fruits and spinach. The main usage of Apocarotenal is in the coloring of food, beverages, cosmetics, and pharmaceutical industry.
BERG LLC, a Boston- based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the presentation of three posters on the progression of its oncology and artificial intelligence/ Biomarker portfolio at the European Society of Medical Oncology 2018 Annual Congress being held October 19-23, 2018
Harrisburg, NC 10/19/2018 Marketinsightsreports provides "Global Bevacizumab Biosimilar Market Insights, Forecast To 2025" which includes the estimation of market size for value and volume. Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bevacizumab Biosimilar Market, to estimate the size of v
BeyondSpring Inc., a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company will report second-quarter 2018 financial results and host an operational and clinical update conference call on Tuesday, October 23, 2018, at 8:00 a.m. Eastern Time. About BeyondSpring.
via NEWMEDIAWIRE BioCorRx Inc., a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the Company s R&D subsidiary, BioCorRx Pharmaceuticals, has acquired a portfolio of six Therakine Biodelivery GmbH patent families that broadly cover sustained release delivery platforms for t
BL-8040 in combination with KEYTRUDA demonstrated encouraging disease control and overall survival in patients with metastatic pancreatic cancer. Tel Aviv, Israel- BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced top-line results from the dual combination arm of the Phase 2 a...
Albany, NY 10/19/2018 Calamus root is rich in vitamin C, hence taken as a dietary vitamin supplement on the regular basis to nourish the replicating cells. Since calamus root supplement is obtained from a natural source, consumers show more towards it. Due to the presence of anti-oxidant nutrients, calamus root is highly utilized in nutraceut
PETACH TIKVA- Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver and inflammatory diseases, today announced that its CEO, Dr. Can-Fite's is currently enrolling patients for a Phase II NAFLD/NASH study in three Israeli sites, including Hadassah Medical Center, Jerusalem, and t
According to report by Grand View Research, Inc. The global cancer supportive care drugs market size is expected to be valued at USD 23.5 billion by 2022. The market to be driven by large number of side-effects associated with cancer treatment, increasing uptake of biosimilars, and availability of effective treatment methods, including target speci
At this year s American Society of Radiation Oncology annual meeting in San Antonio, Texas, October 21-24, 2018, Canon Medical Systems USA, Inc. will showcase its recently FDA- cleared Aquilion Precision TM, the world s first Ultra-High Resolution CT system. The Aquilion Precision sets a new bar for CT imaging, said Dominic Smith, senio